Related Experiment Video
Updated: Aug 7, 2026
14:55
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis
T R Hylan1, W H Crown, L Meneades
1Global Health Outcomes Research, Eli Lilly and Company, Indianapolis, IN 46285-2128, USA.
Medical Care
|April 27, 1999
Summary
Choosing the right antidepressant, like sertraline or paroxetine, impacts initial treatment duration. This study shows initial selective serotonin reuptake inhibitor (SSRI) selection influences patient adherence to depression treatment guidelines.
Area of Science:
- Pharmacology
- Psychiatry
- Health Services Research
Background:
- Real-world antidepressant use patterns offer insights into guideline adherence.
- Understanding duration and patterns of antidepressant use is crucial for effective depression management.
Purpose of the Study:
- To assess how initial selective serotonin reuptake inhibitor (SSRI) selection affects antidepressant use patterns and duration.
- To analyze antidepressant prescribing patterns in US outpatients with depression.
Main Methods:
- Analysis of prescription and medical claims data (MarketScan, 1993-1994).
- Logistic regression used to identify determinants of antidepressant use for 1,034 patients.
- Focused on initial therapy with paroxetine, sertraline, or fluoxetine.
Main Results:
- Patients starting sertraline or paroxetine were less likely to obtain four or more prescriptions within six months compared to those on fluoxetine.
- Initial SSRI choice significantly influenced the early pattern and duration of antidepressant therapy.
Conclusions:
- Antidepressant selection is a key factor in initial treatment duration and pattern.
- Findings align with current recommendations for depression treatment guidelines.
Related Concept Videos
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.